DR SRIPARNA KUNDU SEN,DR ABHIJIT SENGUPTA,DR KAUSIK SEN,MR SOURAV PAL
申请号：
IN201631032500
公开号：
IN201631032500A
申请日:
2016.09.23
申请国别(地区):
IN
年份:
2018
代理人:
摘要：
The present invention relates to an antidiabetic compound. More particularly, the present invention relates to the antidiabetic compound which consists of SGLT2 (Sodium dependent glucose co-transporter protein 2) and GLUT 2 (Glucose transporter protein 2). Moreover this invention relates to the antidiabetic compound wherein Glucose transporter 2 (GLUT2) is a transmembrane carrier protein that enables protein facilitated glucose movement across cell membranes. This invention also relates to the antidiabetic compound which has a plurality of advantages of reasonable simple process, low cost and the like.
